Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same
Abstract:
The present invention relates to high purity cangrelor, pharmaceutical formulations comprising high purity cangrelor as an active ingredient, methods for preparing such compounds and formulations, and methods for using the pharmaceutical formulations in the inhibition of platelet activation and aggregation.
Information query
Patent Agency Ranking
0/0